By Several reports have described a relapse of certain autoimmune kidney diseases in patients after they’ve received COVID-19 vaccines, but it’s unclear if this association is real or a coincidence. In a recent population-level study published in Journal of the American Society of Nephrology (JASN), investigators found that a second or third dose of COVID-19 vaccine was associated with higher relative risk but low absolute increased risk of disease relapse.
Population-level study provides reassuring data on the risk of kidney disease relapse after COVID-19 vaccination
Specialist researcher holding microscope slide analyzing blood sample working at coronavirus vaccine development during virus examination in microbiology hospital laboratory. Biochemistry experiment
Comments